Faculty and staff from the Center for Pharmacoepidemiology and Treatment Science attended the International Society of Pharmacoepidemiology’s annual conference in Copenhagen, Denmark in August 2022.
ISPE is an international organization dedicated to advancing the health of the public by providing a global forum for the open exchange of scientific information and for the development of policy, education and advocacy for the field of pharmacoepidemiology.
Research presentations included:
Tobias Gerhard, BSPharm, PhD, FISPE
Founding Director, Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS) Interim Director, Rutgers Institute for Health, Health Care Policy and Aging Research President, International Society of Pharmacoepidemiology
Dr. Gerhard assumed the role as President of ISPE at the conference.
Principles of Pharmacoepidemiology
Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients in the UK with and without Chronic Kidney Disease, 2006-2020
Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
Pediatric Psychotropic Prescriptions Dispensed in the US Early in the COVID-19 Pandemic
How Can We Mitigate Publication of Poorly Conducted RWE Studies?
Soko Setoguchi, MD, DrPH, FISPE
Core Member, PETS Professor of Medicine, Director of Clinical Research Education, Director of Clinician Researcher Track, Medicine Residency Program, Department of Medicine, Rutgers Robert Wood Johnson Medical School (RWJMS) Professor of Epidemiology, Rutgers School of Public Health
Practical Skills in Protocol Writing and Statistical Analytic Programming Relevant to Pharmacoepidemiology
Data Sourced Heterogeneity in Multi-Data Base Pharmacoepidemiologic Studies: An ISPE-Sponsored Scoping Review
Representing and Leveraging Heterogeneity Between Data Sources in Multi-Database Pharmacoepidemiologic Studies
Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients in the UK with and without Chronic Kidney Disease, 2006-2020
Claims-Based Algorithm to Define Breast Cancer Recurrence in SEER-Medicare Data
Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022
Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center
Farzin Khosrow-Khavar, PhD
Core Member, PETS Instructor, Epidemiology, Department of Biostatistics and Epidemiology, Rutgers School of Public Health
Aromatase Inhibitors and the Risk of Parkinson’s Disease: Population-Based Cohort Study
Elizabeth Suarez, PhD, MPH
Core Member, PETS Instructor, Epidemiology, Department of Biostatistics and Epidemiology, Rutgers School of Public Health
Neonatal and Maternal Adverse Outcomes Following Use of Buprenorphine and Methadone for Treatment of Opioid Use Disorder in Pregnancy
Psychostimulant Use During Pregnancy and the Risk of Neurodevelopmental Disorders in Children
Daniel Horton, MD, MSCE
Core Member, PETS Assistant Professor, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School Dr. Horton was awarded a special ISPE award for contributions to public health associated with the COVID-19 pandemic.
Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
Pediatric Psychotropic Prescriptions Dispensed in the US Early in the COVID-19 Pandemic
Brian L. Strom, MD, MPH
Chancellor at Rutgers Biomedical and Health Sciences Editor-in-Chief, Pharmacoepidemiology and Drug Safety
Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
Chintan Dave, PharmD, PhD
Core Member, PETS Assistant Professor of Pharmacy, Rutgers Ernest Mario School of Pharmacy
Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients in the UK with and without Chronic Kidney Disease, 2006-2020
Cardiovascular Outcomes in Patients with Type 2 Diabetes Who Added Either GLP1 Receptor Agonists or DDP4 Inhibitors to SGLT2 Inhibitor Therapy
Cecilia Huang
Research Project Manager and Senior Data Analyst, Institute for Health, Health Care Policy and Aging Research
Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
Stephen Crystal, PhD
Director, Rutgers Center for Health Services Research Board of Governors Professor of Health Services Research, Rutgers University
Changes in Incidence and Characteristics of Juvenile Idiopathic Arthritis Diagnoses from ICD-9-CM to ICD-10-CM
Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US
Greta Bushnell, PhD, MSPH
Core Member, PETS Assistant Professor, Epidemiology, Department of Biostatistics and Epidemiology, Rutgers School of Public Health
Pediatric Psychotropic Prescriptions Dispensed in the US Early in the COVID-19 Pandemic
Benjamin Bates, MD
Core Member, PETS Instructor, Rutgers-RWJMS Department of Medicine
Claims-Based Algorithm to Define Breast Cancer Recurrence in SEER-Medicare Data
Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022
Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center
Yola Moride, PhD, FISPE
Research Professor, PETS
Pharmacoepidemiologists’ Toolbox for Professional Empowerment
Impact of the COVID-19 Pandemic on Drug Safety Surveillance: An Analysis of the Canadian Spontaneous Reporting Database
Should We Worry About Flare-Ups Following Vaccination in Systematic Lupus Patients? A Nationwide Case-Crossover Study Using the French Healthcare Database
Vaccination and Acute Flares in Rheumatoid Arthritis: A Nationwide Case-Crossover Study Using the French SNDS Health Care Databases
Does Hydroxychloroquine Prevent Cardiovascular Events in Systematic Lupus Erythematosus Patients?
Julia Liaw
PETS Trainee PharmD Candidate, Rutgers Ernest Mario School of Pharmacy
Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients in the UK with and without Chronic Kidney Disease, 2006-2020
Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022
Aayush Visaria
Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022
Garima Mittal
Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center
Mackenzie Henderson
Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center
Haoqian Chen
Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center
Tania J. Atanassova
Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
Joanna Madej
Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
Sarah McGuire
Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis
